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(57) ABSTRACT 
An apparatus for determining cardiac performance in the 
patient. The apparatus includes a conductance catheter for 
measuring conductance and blood Volume in a heart chamber 
of the patient. The apparatus includes a processor for deter 
mining instantaneous Volume of the Ventricle by applying a 
non-linear relationship between the measured conductance 
and the volume of blood in the heart chamber to identify 
mechanical strength of the chamber. The processor is in com 
munication with the conductance catheter. Methods for deter 
mining cardiac performance in a patient. Apparatuses for 
determining cardiac performance in a patient. 
17 Claims, 5 Drawing Sheets 
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1. 
METHOD AND APPARATUS FOR 
DETERMINING CARDAC PERFORMANCE 
NAPATIENT WITH A CONDUCTANCE 
CATHETER 
CROSS-REFERENCE TO RELATED 
APPLICATIONS 
This is a continuation of U.S. patent application Ser. No. 
13/066,201 filed Apr. 8, 2011, now U.S. Pat. No. 8,929,976, 
which is a divisional of U.S. patent application Ser. No. 
10/568,912 filed Nov. 1, 2007, now U.S. Pat. No. 7,925,335 
issued Apr. 12, 2011, which is a 371 of international applica 
tion PCTUS04/28573 filed Sep. 3, 2004, which is an interna 
tional application of U.S. provisional application Ser. No. 
60501,749 filed Sep. 9, 2003, all of which are incorporated by 
reference herein. 
FIELD OF THE INVENTION 
The present invention is related to measuring instantaneous 
ventricular volume in the heart of a patient. More specifically, 
the present invention is related to measuring instantaneous 
ventricular volume in the heart of a patient by removing the 
contributor to conductance of muscle, and applying a non 
linear relationship to the measured conductance and the Vol 
ume of blood in the heart. 
BACKGROUND OF THE INVENTION 
Measurements of electrical conductance using a tetrapolar 
admittance catheter are used to estimate instantaneous ven 
tricular Volume in animals and humans. The measurements of 
Volume are plotted against Ventricular pressure to determine 
several important parameters of cardiac physiologic function. 
A significant Source of uncertainty in the measurement is 
parallel conductance due to current in the Ventricular muscle. 
The estimated volume is larger than the blood volume alone, 
which is required for the diagnostic measurement. Further 
more, presently, a linear relationship between conductance 
and estimated Volume is used to calibrate the measurements. 
The actual relationship is Substantially nonlinear. 
The invention comprises an improved method for estimat 
ing instantaneous blood Volume in a Ventricle by Subtracting 
the muscle contribution form the total conductance measured. 
The method relies on measuring the complex admittance, 
rather than apparent conductance (admittance magnitude), as 
is presently done. Briefly, the improvement consists of mea 
Suring the phase angle in addition to admittance magnitude 
and then directly subtracting the muscle component from the 
combined measurement, thereby improving the estimate of 
instantaneous blood Volume. The technique works because 
the electrical properties of muscle are frequency-dependent. 
while those of blood are not. We propose this calibration 
technique as a Substantial improvement in clinical and 
research instrumentation calibration methods. 
The invention comprises an improved method for estimat 
ing instantaneous Volume of a ventricle by applying a non 
linear relationship between the measured conductance and 
the Volume of blood in the Surrounding space. The nonlinear 
calibration relation has been determined from experiments 
and numerical model studies. This calibration technique is a 
Substantial improvement in clinical and research instrumen 
tation calibration methods. 
SUMMARY OF THE INVENTION 
The present invention pertains to an apparatus for deter 













comprises a conductance catheter for measuring conductance 
and blood volume in a heart chamber of the patient. The 
apparatus comprises a processor for determining instanta 
neous Volume of the Ventricle by applying a non-linear rela 
tionship between the measured conductance and the Volume 
of blood in the heart chamber to identify mechanical strength 
of the chamber. The processor is in communication with the 
conductance catheter. 
The present invention pertains to a method for determining 
cardiac performance in the patient. The method comprises the 
steps of measuring conductance and blood Volume in a heart 
chamber of the patient with a conductance catheter. There is 
the step of determining instantaneous Volume of the Ventricle 
by applying a non-linear relationship between the measured 
conductance and the volume of blood in the heart chamber to 
identify mechanical strength of the chamber with a processor. 
The processor in communication with the conductance cath 
eter. 
The present invention pertains to an apparatus for deter 
mining cardiac performance in a patient. The apparatus com 
prises a conductance catheter for measuring conductance in a 
heart chamber of the patient, where the conductance includes 
contributions from blood and muscle with respect to the heart 
chamber. The apparatus comprises a processor for determin 
ing instantaneous Volume of the heart chamber by removing 
the muscle contribution from the conductance. The processor 
is in communication with the conductance catheter. 
The present invention pertains to a method for determining 
cardiac performance in a patient. The method comprises the 
steps of measuring conductance in a heart chamber of the 
patient with a conductance catheter, where the conductance 
includes contributions from blood and muscle with respect to 
the heart chamber. There is the step of determining instanta 
neous volume of the heart chamber by removing the muscle 
contribution from the conductance with a processor, the pro 
cessor in communication with the conductance catheter. 
The present invention pertains to an apparatus for deter 
mining cardiac performance in the patient. The apparatus 
comprises a conductance catheter having measuring elec 
trodes for measuring conductance in a heart chamber of the 
patient. The apparatus comprises a processor for determining 
instantaneous Volume of the heart chamber according to 
Vol(t) = (BG) ro - Y, Oh, 
where: B(G)=the field geometry calibration function (di 
mensionless), Y(t) the measured combined admittance, O, 
is blood conductivity, L is distance between measuring elec 
trodes, and Y, the parallel leakage admittance, dominated by 
cardiac muscle, the processor in communication with the 
conductance catheter. 
The present invention pertains to a method for determining 
cardiac performance in the patient. The method comprises the 
steps of measuring conductance and blood Volume in a heart 
chamber of the patient with a conductance catheter having 
measuring electrodes. There is the step of determining instan 
taneous Volume of the Ventricle according to 
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where: B(G)=the field geometry calibration function (di 
mensionless),Y(t) the measured combined admittance, O, is 
blood conductivity, L is distance between measuring elec 
trodes, and Y, the parallel leakage admittance, dominated by 
cardiac muscle, to identify mechanical strength of the cham 
ber with a processor. The processor is in communication with 
the conductance catheter. 
BRIEF DESCRIPTION OF THE DRAWINGS 
In the accompanying drawings, the preferred embodiment 
of the invention and preferred methods of practicing the 
invention are illustrated in which: 
FIG. 1 shows a four electrode catheter in volume cuvette. 
FIG. 2 is a plot for estimating parallel conductance. 
FIG. 3 is a plot of apparent conductivity of cardiac muscle 
as a function of frequency in CD1 mice in vivo at 37°C. 
FIG. 4 shows a circuit diagram of a catheter and a mea 
Surement system for an open circuit load. The Small triangles 
are the common node for the instrument power Supply. 
FIG. 5 is a plot of catheter phase effects for saline solutions 
from 720 to 10,000 uS/cm from 1 kHz to 1 MHz. Apparent 
conductivity (m) of Saline solutions (LS/cm). 
FIG. 6 is a plot of conductance vs. Volume in mouse-sized 
calibration cuvette. 
FIG. 7 is a schematic representation of the apparatus of the 
present invention. 
FIG. 8 is a cylinder-shaped murine LV model: both blood 
and myocardium are modeled as cylinders. 
FIG.9 is a comparison between true volume and estimated 
volume by the new and Baan’s equations in FEMLAB simu 
lations. 
FIG. 10 is a comparison between true volume and esti 
mated Volume using the new and Baan's equations in Saline 
experiments. 
DETAILED DESCRIPTION 
Referring now to the drawings wherein like reference 
numerals refer to similar or identical parts throughout the 
several views, and more specifically to FIG.7 thereof, there is 
shown an apparatus for determining cardiac performance in 
the patient. The apparatus comprises a conductance catheter 
12 for measuring conductance and blood Volume in a heart 
chamber of the patient. The apparatus comprises a processor 
14 for determining instantaneous volume of the ventricle by 
applying a non-linear relationship between the measured con 
ductance and the volume of blood in the heart chamber to 
identify mechanical strength of the chamber. The processor 
14 is in communication with the conductance catheter 12. 
Preferably, the apparatus includes a pressure sensor 16 for 
measuring instantaneous pressure of the heart chamber in 
communication with the processor 14. The processor 14 pref 
erably produces a plurality of desired wave forms at desired 
frequencies for the conductance catheter 12. Preferably, the 
processor 14 produces the plurality of desired wave forms at 
desired frequencies simultaneously, and the processor 14 
separates the plurality of desired wave forms at desired fre 
quencies the processor 14 receives from the conductance 
catheter 12. The conductance catheter 12 preferably includes 
a plurality of electrodes 18 to measure a least one segmental 
Volume of the heart chamber. 
Preferably, the non-linear relationship depends on a num 
ber of the electrodes 18, dimensions and spacing of the elec 













the electrodes 18 of the catheter 12 arc disposed. The non 
linear relationship may he expressed as (or a Substantially 
similar mathematical form): 
B(G)(o-0.928Sn)=1+1.774(107.481*10 G-2057) 
Alternatively, an approximate calibration factor may be 




where: G is the measured conductance (S), the calculations 
have been corrected to the conductivity of whole blood at 
body temperature (0.928 S/m), and 2057 is the asymptotic 
conductance in LS when the cuvette is filled with a large 
volume of whole blood. Preferably, 
Oh, 
where: B(G)=the field geometry calibration function (di 
mensionless). Y(t) the measured combined admittance, O, is 
blood conductivity, L is distance between measuring elec 
trodes, and Y, the parallel leakage admittance, dominated by 
cardiac muscle. 
The pressure sensor 16 preferably is in contact with the 
conductance catheter 12 to measure ventricular pressure in 
the chamber. Preferably, the plurality of electrodes 18 
includes intermediate electrodes 20 to measure the instanta 
neous Voltage signal from the heart, and outer electrodes 22 to 
which a current is applied from the processor 14. The pressure 
sensor 16 preferably is disposed between the intermediate 
electrodes 20. Preferably, the processor 14 includes a com 
puter 24 with a signal synthesizer 26 which produces the 
plurality of desired wave forms at desired frequencies and a 
data acquisition mechanism 28 for receiving and separating 
the plurality ofdesired wave forms at desired frequencies. The 
computer 24 preferably converts conductance into a Volume. 
Preferably, the computer 24 produces a drive signal having a 
plurality of desired wave forms at desired frequencies to drive 
the conductance catheter 12. 
The present invention pertains to a method for determining 
cardiac performance in the patient. The method comprises the 
steps of measuring conductance and blood Volume in a heart 
chamber of the patient with a conductance catheter 12. There 
is the step of determining instantaneous Volume of the ven 
tricle by applying a non-linear relationship between the mea 
sured conductance and the volume of blood in the heart cham 
ber to identify mechanical strength of the chamber with a 
processor 14. The processor 14 in communication with the 
conductance catheter 12. 
Preferably, there is the step of measuring instantaneous 
pressure ofthe heart chamber with a pressure sensor 16 in 
communication with the processor 14. There is preferably the 
step of producing a plurality of desired wave forms at desired 
frequencies for the conductance catheter 12. Preferably, the 
producing step includes the step of producing the plurality of 
desired wave forms at desired frequencies simultaneously, 
and including the step of the processor 14 separating the 
plurality of desired wave forms at desired frequencies the 
processor 14 received from the conductance catheter 12. The 
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producing step preferably includes the step of producing with 
the processor 14 the plurality of desired wave forms at desired 
frequencies simultaneously. 
Preferably, the determining step includes the step of apply 
ing the non-linear relationship according to the following (or 
its mathematical equivalent): 
B(G)(o-0.928S/m)-1+1.774(107.481*10 G-2057) 
where: G is the measured conductance (S), the calculations 
have been corrected to the conductivity of whole blood at 
body temperature (0.928 S/m), and 2057 is the asymptotic 
conductance in pS when the cuvette is filled with a large 
volume of whole blood. Or, alternatively, an approximate 
geometry calibration factor may be used: 
where C. is determined experimentally or from mathemati 
cal calculations or numerical models. 
The determining step preferably includes the step of deter 
mining instantaneous Volume according to 
Vol(t) = (PG|Ero - Y, 
where: B(G)=the field geometry calibration function (di 
mensionless),Y(t) the measured combined admittance, O, is 
blood conductivity, L is distance between measuring elec 
trodes, and Y, the parallel leakage admittance, dominated by 
cardiac muscle. 
Preferably, the step of measuring instantaneous pressure 
includes the step of measuring instantaneous pressure with 
the pressure sensor 16 in contact with the conductance cath 
eter 12 to measure the ventricular pressure in the chamber. 
The measuring step preferably includes the step of measuring 
at least one segmental Volume of the heart chamber with a 
plurality of electrodes 18 on the conductance catheter 12. 
Preferably, the measuring step includes the steps of applying 
a current to outer electrodes 22 of the plurality of electrodes 
18 from the processor 14, and measuring an instantaneous 
voltage signal from the heart with intermediate electrodes 20 
of the plurality of electrodes 18. 
The step of measuring instantaneous pressure preferably 
includes the step of measuring instantaneous pressure with 
the pressure sensor 16 disposed between the intermediate 
electrodes 20 and the outer electrodes 22. Preferably, the 
producing with the processor 14 step includes the step of 
producing with a signal synthesizer 26 of a computer 24 the 
plurality of desired waveforms at desired frequencies, and the 
processor 14 separating step includes the step of receiving 
and separating the plurality of desired wave forms at desired 
frequencies with a data acquisition mechanism 28 of the 
computer 24. There is preferably the step of converting con 
ductance into a volume with the computer 24. Preferably, 
there is the step of producing with the computer 24 a drive 
signal having the plurality of desired wave forms at desired 
frequencies to drive the conductance catheter 12. 
The present invention pertains to an apparatus for deter 
mining cardiac performance in a patient. The apparatus com 
prises a conductance catheter 12 for measuring conductance 
in a heart chamber of the patient, where the conductance 
includes contributions from blood and muscle with respect to 
the heart chamber. The apparatus comprises a processor 14 
for determining instantaneous Volume of the heart chamber 
by removing the muscle contribution from the conductance. 















Preferably, the apparatus includes a pressure sensor 16 for 
measuring instantaneous pressure of the heart chamber in 
communication with the processor 14. The processor 14 pref 
erably produces a plurality of desired wave forms at desired 
frequencies for the conductance catheter 12. Preferably, the 
processor 14 produces the plurality of desired wavefbrms at 
desired frequencies simultaneously, and the processor 14 
separates the plurality of desired wave forms at desired fre 
quencies the processor 14 receives from the conductance 
catheter 12. The processor 14 preferably measures complex 
admittance with the conductance catheter 12 to identify the 
muscle contribution. 
Preferably, the complex admittance is defined as 
Y=Gm+joCm (Y subscript p) 
where 
Cm=capacitance component of muscle (F-Farads) (C sub 
Script m) 
() angular frequency (radianssecond) (greek “omega'-2 
pif) 
Gm=conductance of muscle (S=Siemens) (G subscript m). 
The conductance preferably is defined as 
where Gb-conductance of blood (S) (G subscript b). 
The present invention pertains to a method for determining 
cardiac performance in a patient. The method comprises the 
steps of measuring conductance in a heart chamber of the 
patient with a conductance catheter 12, where the conduc 
tance includes contributions from blood and muscle with 
respect to the heart chamber. There is the step of determining 
instantaneous volume of the heart chamber by removing the 
muscle contribution from the conductance with a processor 
14, the processor 14 in communication with the conductance 
catheter 12. 
Preferably, there is the step of measuring instantaneous 
pressure of the heart chamber with a pressure sensor 16 in 
communication with the processor 14. There is preferably the 
step of producing a plurality of desired wave forms at desired 
frequencies for the conductance catheter 12. Preferably, the 
producing step includes the step of producing the plurality of 
desired wave forms at desired frequencies simultaneously, 
and including the step of the processor 14 separating the 
plurality of desired wave forms at desired frequencies the 
processor 14 received from the conductance catheter 12. The 
producing step preferably includes the step of producing with 
the processor 14 the plurality of desired wave forms at desired 
frequencies simultaneously. Preferably, there is the step of 
measuring complex admittance with the conductance cath 
eter 12 to identify the muscle contribution. 
The measuring the complex admittance step preferably 
includes the step olmeasuring the complex admittance 
according to 
Yp=Gm+icoCm (Y subscript p) 
where 
Cm=capacitance component of muscle (F-Farads) (C sub 
Script m) 
() angular frequency (radianssecond) (greek “omega'-2 
pif) 
Gm=conductance of muscle (S Siemens) (G subscript m). 
Preferably, the determining step includes the step of deter 
mining instantaneous Volume based on conductance defined 
aS 
Y(t)=Gb+Gm+icoCm 
where Gb-conductance of blood (S) (G subscript b). 
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The present invention pertains to an apparatus for deter 
mining cardiac performance in the patient. The apparatus 
comprises a conductance catheter 12 for measuring conduc 
tance in a heart chamber of the patient. The apparatus com 
prises a processor 14 for determining instantaneous Volume 
of the heart chamber according to 
Vol(t) = (BG) ro - Y, Ot, 
where: B(G)=the field geometry calibration function (di 
mensionless),Y(t) the measured combined admittance, O, is 
blood conductivity, L is distance between measuring elec 
trodes, and Y, the parallel leakage admittance, dominated by 
cardiac muscle, the processor 14 in communication with the 
conductance catheter 12. 
The present invention pertains to a method for determining 
cardiac performance in the patient. The method comprises the 
steps of measuring conductance and blood Volume in a heart 
chamber of the patient with a conductance catheter 12. There 
is the step of determining instantaneous Volume of the ven 
tricle according to 
Vol(t) = (BG) ro - Y, Ot, 
where: B(G)=the field geometry calibration function (di 
mensionless),Y(t) the measured combined admittance, O, is 
blood conductivity, L is distance between measuring elec 
trodes, and Y, the parallel leakage admittance, dominated by 
cardiac muscle, to identify mechanical strength ofthe cham 
ber with a processor 14. The processor 14 is in communica 
tion with the conductance catheter 12. 
The classic means to determine left ventricular pressure 
volume (PV) relationships in patients on a beat-by-beat basis 
is through the use of the conductance (volume) catheter 12. 
The electric field that it creates in the human left ventricle at 
the time of heart catheterization is the only technology 
capable of measuring instantaneous left ventricular Volume 
during maneuvers such as transient occlusion of the inferior 
vena cava. Such maneuversallow determination of the wealth 
of information available from the PV plane including: end 
systolic elastance, diastolic compliance, and effective arterial 
elastance. However, use of conductance technology in 
patients with dilated hearts whose LV Volumes can range 
from 200 to 500 ml has been problematic. 
The G-V method measures the conductance between elec 
trodes 18 located in the LV and aorta. A minimum of four 
electrodes 18 is required to prevent the series impedance of 
the electrode-electrolyte interfaces from distorting the mea 
Surement. Typically, the two current source-sink electrodes 
are located in the aorta and in the LV near the apex (electrodes 
1 and 4 in FIG. 1). The potential difference between the 
potential measuring electrodes (2 and 3) is used to calculate 
the conductance: G =I/V. The governing assumption is that the 
current density field is sufficiently uniform that the volume 
and conductance are simply related by Baan's equation 1: 
1 L. (1) 













where: C. is the geometry factor (a dimensionless constant), 
L is the center-to-center distance between Voltage sensing 
electrodes (2 and 3) (m), O, is the conductivity of blood (S/m), 
G(t) is the measured instantaneous conductance (S), and G is 
the parallel conductance (S) in cardiac muscle (G-0 in the 
calibration cuvette of FIG. 1). 
Two limitations inherent in the state-of-the-art technique 
interfere with accurate measurements: 1) the electric field 
around the sensing electrodes 18 is not uniform, leading to a 
non-linear relationship between measured conductance and 
ventricular volume which has decidedly lower sensitivity to 
large Volumes, and 2) the parallel conductance signal added 
by Surrounding cardiac muscle adds virtual Volume to the 
measurement. The new technique improves the estimate of 
the parallel muscle conductance based on the measurement of 
complex admittance at two or more frequencies, rather than 
using the admittance magnitude, as is presently done. Fur 
thermore, the inherent non-linearity of conductance vs. Vol 
ume is usually compensated by establishing a piece-wise 
linear approximation to the sensitivity curve (Vol vs. G) in the 
region of operation. That is, a is actually a function of the 
diameter of the volume in FIG. 1; but is assumed constant 
over the operating range of a measurement, ESV to EDV. 
The electrical properties of cardiac muscle are frequency 
dependent 6-14 while those of blood are not 15-18. The 
admittance measurement at (at least) two frequencies can be 
used to separate the muscle component from the combined 
muscle-blood signal. Measurement of the phase angle of the 
admittance is a more sensitive indicator of the muscle signal 
than the magnitude of the admittance, which is currently 
measured. Information contained in the phase angle can 
improve the overall accuracy of the dual frequency admit 
tance system. This reformulation of the measurement allows 
one to verify that the effective sensing volume actually 
reaches the Ventricular muscle in the case of an enlarged 
heart. 
In the operation of the invention, the parallel conductance 
signal is presently compensated by three methods: 1) hyper 
tonic saline injection 19, 20, 2) occlusion of the inferior 
Vena cava (IVC) 21, and 3) conductance measurement at 
two frequencies 22, 23. In the first approach, a known Vol 
ume of hypertonic saline (usually 10% NaCl) is injected and 
the beat-by-beat conductance signal measured as it washes 
through the LV during several beats. The End Diastolic Con 
ductance (EDG) is plotted against End Systolic Conductance 
(ESG), and the resulting line is projected back to the line of 
equal values (EDG ESG when stroke volume=0), and the 
remainder is the estimate of parallel conductance, G. (see 
FIG. 2.). In the second approach, occlusion of the IVC, 
shrinks the LV volume, but the result is analyzed in the same 
way as FIG. 2. The third approach attempted to use the fre 
quency dependence of muscle to identify the parallel conduc 
tance 22, 23. This is similar to the approach described here, 
but different in that the particular frequencies were limited to 
a maximum of about 30 kHz and only the magnitude of the 
combined signal was used. A maximum frequency of 100 
kHz is used here to better separate the muscle from the com 
bined signal; further, the phase angle is a much more sensitive 
indicator of muscle than admittance magnitude alone. 
Each of the parallel conductance compensation approaches 
has undesirable features. Hypertonic saline injection creates 
an aphysiologic electrolyte load that is undesirable in the 
failing heart. IVC occlusion brings the ventricular free wall 
and septum closer to the electrode array and artificially 
inflates the parallel conductance. The dual frequency mea 
surements are able to identify a difference signal between 
blood and cardiac muscle, but measurement using the mag 
US 9,380,946 B2 
nitude of admittance alone is not sufficiently sensitive to yield 
satisfying results, and the particular frequencies used in the 
past are not the best to separate the two signals. There are 
other considerations in the dual-frequency measurement 
which affect overall accuracy—notably the parasitic imped 
ances in the catheter 12 itself which must be compensated 
before reliable calculations may be made. The present inven 
tion is a significant improvement to the dual frequency 
method; it uses measurements of the complex admittance to 
more accurately identify the parallel muscle Volume signal 
and does not require injecting fluids or changing the LV 
Volume to complete. 
frequency Dependence of Muscle Electrical Properties: 
Electrolytic solutions, blood and all semiconducting materi 
als have an electrical conductivity, O, that is essentially inde 
pendent of frequency. Dielectric materials have an electric 
permittivity, e (F/m): in essence, permittivity is a measure of 
the polarizable dipole moment per unit volume in a material 
14. A general material has both semiconducting and dielec 
tric properties, and each aspect contributes to the total current 
density vector, J. (A/m) in a vector electric field, E (V/m). 
The conductivity, O, results in conduction current density 
according to Ohm's Law, and the permittivity, e, contributes 
“displacement current density in a harmonic (i.e. sinusoidal) 
electric field, as reflected in the right hand side of Ampere's 
Law 40: 
J. (O+joe).E (2) 
where: j=V-1, and (0–290 f-the angular frequency (r/s). 
J, is complex even if E is real—in other words, J and E are 
not in phase with each other unless (De is Small with respect to 
O. Most all tissues behave as semiconductors at all frequen 
cies below about 10 MHZ because podcoe. The remarkable 
exception is muscle tissue in vivo or very freshly excised, 
10-12, and our own unpublished measurements. To cali 
brate this discussion, water has a very strong dipole moment, 
and has a relative permittivity of around 80 at frequencies 
below about 1 MHz; and the relative permittivities of most 
tissues are, therefore, usually dominated by their water con 
tent. Muscle, in contrast, has a very high relative permittivity: 
around 16,000 in the 10 kHz to 100 kHz range (almost 200 
times that of water)11, owing to the trans-membrane charge 
distribution. Consequently, coe are able to observe the fre 
quency dependence of muscle total current density since (De is 
larger than O for frequencies above about 15 kHz. 
For example, the apparent conductivity of murine cardiac 
muscle using a surface tetrapolar probe shows a reliable and 
repeatable frequency dependence. In FIG. 3, the indicated 
conductivity increases significantly above about 10 kHz. The 
conductivity in the figure includes some permittivity effects: 
the measurement device actually indicates the magnitude of 
the (O+(pe) terminequation 2. For muscle, it is more accurate 
to think in terms of “admittivity', m=O+jcoe. O=1,800LLS/cm 
(0.18 S/m) from the low frequency portion ofthe plot, and 
estimate that e=16,000 ec (F/m) which compares well with 
published data. In the figure, the parasitic capacitances of the 
Surface probe have been compensated Out using measure 
ments of the surface probe on electrolytic solutions with the 
same baseline conductivity as muscle. 
Numerical Model Studies: Numerical models of the 
murine catheter in a mouse LV were executed at Volumes 
representative of the normal ESV and EDV in the mouse. The 
numerical model was an enhanced version of the model used 
for the cuvette studies: each control volume (CV) could he 
assigned a different value of electrical conductivity, O. The 
model spatial resolution and FDM calculational approach 













tions were required for convergence, however, around 400, 
000 iterations. This is because the electrical boundary condi 
tions ofthe inhomogeneous media Substantially increase the 
number of trials required to settle to the final solution. Models 
were completed using realistic volumes for ESV and EDV 
derived from conductance catheter 12 data: 19 ul and 45 ul, 
respectively (ejection fraction=60%). Electrical conductivi 
ties for blood, cardiac muscle and aorta were: O, 0.928 S/m, 
O=0.0945 S/m at 10kHz and 0.128 S/m at 100kHz, O=0.52 
S/m 41, respectively. All of the properties are real-valued in 
the model—the complex nature ofnuscle has not been 
included in the preliminary studies. The ventricular free wall 
endocardial Surface was treated as a Smooth ellipse, and the 
LV was modeled as an ellipsoid of revolution. The geometry 
was considerably simplified over the actual LV for two rea 
sons: 1) the purpose of the model was to identify the expected 
order-of-magnitude of muscle contribution to the measured 
conductance, 2) the resources and time available did not 
permit developmentofa detailed 3-D geometry, nor the use of 
more accurate finite element method (FEM) models. 
Table 1 compares FDM model and experiment data. The 
model consistently under-estimates the measured conduc 
tances: by about 11% and 35% at 10 kHz, and by 30% and 
47% at 100 kHz. The comparisons at 10 kHz are least sensi 
tive to uncertainty in tissue electrical properties and catheter 
12 effects. Deviations at this frequency arc more likely due to 
geometric simplifications in the model and under-estimation 
of the appropriate LV volume to use. 
TABLE 1 
Summary of model and experimental conductance values (IS). 
Experimental data are the means of six normal mice 28, 
numbers in parentheses are standard deviations. 
Source EDV ESV 
FDM Model (a) 10 kHz 1419 LS 844 IS 
Experiment (a) 10 kHz 1600 (500) 1300 (400) 
FDM Model (a) 100 kHz 1493 905 
Experiment (a) 100 kHz 2100 (400) 1700 (400) 
The 100 kHz measurements reveal an additional effect due 
to the complex nature of the electrical properties of muscle 
and the effect of capacitance between the wires in the con 
ductance catheter 12. While the actual values ofthe calculated 
conductance are subject to many uncertainties, the differ 
ences between 10 kHz and 100 kHz values in the model are 
due only to the electrical properties of muscle. So, in Table 1 
it looks at first glance as though the model work has severely 
underestimated the capacitive effects in muscle. However, it 
must be noted that the reported in vivo measurements do not 
compensate out the Stray capacitance in the catheter 12 at 100 
kHz. At this point, it is not clear precisely how much of the 
apparent frequency-dependent signal is due to catheter 12 
capacitance, and how much is due to muscle signal in those 
data. 
The improved muscle parallel conductance compensation 
technique described can be implemented in existing conduc 
tance machines either in embedded analysis Software (real 
time or off-line processing of measured data) or in dedicated 
Digital Signal Processing hardware devices. 
Phase Angle Measurement: There is an embedded diffi 
culty in this measurement which must be addressed: the para 
sitic capacitance of the catheters has effects on the measured 
admittance signal phase angle in addition to the muscle per 
mittivity component. One necessarily measures the two 
together; and a method for compensating out or otherwise 
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dealing with the catheter-induced effects is required. Fortu 
nately, all of the necessary catheter 12 characteristics can be 
measured a priori. We have identified three approaches to this 
problem. 
First, the catheter 12 phase angle effects stem from para 
sitic capacitance between electrode wires in the catheter 12. 
The tetrapolar case is relatively easy to discuss, and the multi 
electrode catheters consist of several repeated combinations 
of the 4-electrode subunit. We can measure the six inter 
electrode parasitic capacitances of the 4-electrode systems 
(FIG. 4). The effect of the inter-electrode capacitances can be 
reduced to a single capacitive admittance in parallel with the 
tissues, C. much larger than any of the C. This can he seen 
in experimental measurements on saline which has no 
observable permittivity effects at frequencies below about 
200 MHz; thus, all capacitance information (frequency-de 
pendent increase in Iml, where m O+(pe) in the signal comes 
from catheter 12 effects (FIG. 5). in FIG. 5 a small conduc 
tivity measurement probe (inter-electrode capacitances from 
60 to 70 pF) has been used to measure the apparent conduc 
tivity (m) of saline solutions between 720 uS/cm (lowest 
line) and 10,000 uS/cm (highestline). The lines cross because 
the point where OAFC)e, moves to higher frequency for 
higher O. C., is approximately 1.5 nF here. 
Second, a lumped-parameter circuit model can be con 
structed for catheter 12 effects and use this model to correct 
the measured potential, AV, to the value it would have in the 
absence of the parasitic capacitances. Third, we can advance 
the measurement plane from the current-source output, I, 
(FIG.5) and voltage measurement location, AV, to the outside 
surfaces of the four electrodes 18 using abilinear transform. 
This is a standard approach in impedance measurement see 
ref. 14, Ch. 5 and requires only a measurement at open 
circuit, short circuit and a normalizing load (say, 1 kS2) to 
accomplish. 
The first approach is the most practical for implementation 
in a clinical instrument: we will subtract the catheter 12 
capacitance, C., (measured a priori) from the total capaci 
tance of the measurement, C, with the remainder: 
C-C-C. The measurement from 2 to 10 kHZ 
includes only the real parts: Yo G+G. At 100 kHz: 
Yoo-G+G+jc)(C+C). Negative values are 
rejected and C, is deterministic and not time-varying. The 
calculation strategy is then: C, Yoo sin(0)/(); 
CnuscCror-Coath: finally, G. G.s. O, Cmuscle,musc (from 
the well known conductance-capacitance analogy 40) and 
G can be subtracted from Yo! to determine G, i.e. 
IYol=G+G. A purely analog approach to this measurement 
is impossible, and a mixed signal approach with extensive 
digital processing required for both catheter 12 compensation 
and phase measurement is used. Based on the model trends 
and measured values of Table 1, it is estimated the relative 
phase angles in the measured admittance ought to be approxi 
mately 4 for EDV and 8° for ESV. The larger phase angle for 
ESV reflects the change in relative proximity of the LV wall. 
The non uniformity of the electrode sensing field is inher 
ent in the single current source electrode geometry of FIG.1. 
Two limiting cases illustrate the origin of this. First, for a 
sufficiently large cuvette or blood volume, the electric and 
current density fields Surrounding electrodes 1 and 4 are 
similar in overall shape to those of a current dipole: the 
magnitude of the current density decreases with the cube of 
the radius. At very large Volume the Voltage measured 
between electrodes 2 and 3 is insensitive to the location of the 
outer boundary. Consequently, the measured conductance 
saturates at large volumes since the sensitivity, AG/AVol=0, 













outer radius of the Volume is minimally larger than the cath 
eter 12 itself. In that case the current density approaches a 
uniform distribution and a approaches 1. Radii between these 
limits cross over from C-1 to C=0. 
The behavior ofa was studied in experiments and numeri 
cal models of a mouse-sized 4-electrode conductance cath 
eter 12 in a volume-calibration cuvette. This catheter 12 has 
L=4.5mm between the centers of electrodes 2 and 3 and is 1.4 
F (i.e. 0.45 mm in diameter). The cuvette was filled with 1M 
saline solution (O=1.52 S/mat room temperature). The results 
are summarized in FIG. 3. in the Figure, “Ideal G” is the line 
C=1. The numerically calculated (squares) and measured 
(circles) conductance in LS are plotted VS. cuvette Volume 
(ul). The measurement sensitivity, AG/AVol, in the figure=C. 
(O/L), and this slope asymptotically approaches 0 for vol 
umes greater than about 150 ul for this catheter 12. This 
behavior is determined solely by the geometry of the current 
density field, and a is independent of the conductivity of the 
Solution. 
Based on the numerical model and experimental results, a 
new calibration equation using B(G) as the geometry calibra 
tion function to replace C. in equation 4: 
(4) 
Vol(t) = (BG) ro - Y, Ob 
where: B(G)=the field geometry calibration function (di 
mensionless),Y(t) the measured combined admittance, O, is 
blood conductivity, L is distance between measuring elec 
trodes, and Y, the parallel “leakage" admittance, dominated 
by cardiac muscle. At small volumes, B(G)=C=1. At large 
volumes, B(G) increases without bound, as expected from the 
model work in FIG. 6. The new calibration function includes 
the non-linear nature of the Volume calculation: since for a 
particular catheter B(G) depends on the conductivity of the 
liquid and on measured G—i.e. on cuvette andor Ventricular 
blood outer radius—it is not simply expressible in terms of 
1/O. The expression for B(G) for the mouse-sized catheter 12 
described above for FIG. 6 data is: 
B(G)(o-0.928S/m)-1+1.774(10748x10"G2057) (5) 
where: G is the measured conductance (S), the calculations 
have been corrected to the conductivity of whole blood at 
body temperature (0.928 S/m), and 2057 is the asymptotic 
conductance in LS when the cuvette is filled with a large 
volume of whole blood. Here f3(G) depends only on the real 
part of Y because the cuvette measurements do not contain 
muscle. In use, G is the real part of Y(t)-Y), and any 
imaginary part of the signal is rejected since it must come 
from a muscle component, or from the instrumentation. As 
required, B(G) approaches 1 as G becomes Small compared to 
the asymptote, 2057 uS. 
The improved calibration method can be implemented in 
existing conductance machines either in embedded analysis 
Software (real-time or off-line processing of measured data) 
or in dedicated Digital Signal Processing hardware devices. 
Complex admittance in regard to overall admittance as it 
relates to Y(t)-Y, is as follows. 
C, capacitance component of muscle (F-Farads) (C) 
() angular frequency (radianssecond) (c) 2 Juf) 
Gm=conductance of muscle (S=Siemens) (G) 
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Gb-conductance of blood (S) (G) 
Y(t)=total instantaneous measured admittance (S) (after 
catheter 12 effects have been compensated. 
Y total parallel admittance (everything but blood). The 
cardiac muscle dominates Y.; and thus once Y, is known 
(from the measurement of phase angle-only muscle has 
capacitance and contributes to the phase angle) the estimate 
of G can be improved and thus the volume of blood. 
The following elaborates on the nonlinear relationship 
B(G) between conductance and Volume. 
1. Physical Principle: 
B(G) is a nonlinear function for every admittance (conduc 
tance) catheter 12. The function depends on the number, 
dimensions and spacing of the electrodes 18 used, and on the 
electrical conductivity of the medium which it is in. B(G) is 
determined by the shape of the current field created by the 
electrodes 18. 
2. Experimental Determination 
B(G) may be determined experimentally for any conduc 
tance catheter 12 in cylindrical "cuvettes' in which a solution 
of known electrical conductivity is measured over a range of 
cuvette diameters. The “volume' is the volume of solution 
between the voltage sensing electrodes 18. 
3. Determination by Solution of the Electric Field Equa 
tions 
B(G) may also be determined by Solving the governing 
electric field equations, namely Gauss’ Electric Law—either 
in integral form or in the form of the Laplace at low frequency, 
and the wave equations at high frequency—Subject to appro 
priate boundary conditions. The solution may be by analytical 
means (paper and pencil) or by numerical means, as in a 
digital computer 24 model of the electric andor electromag 
netic fields. For any current field established by two or more 
electrodes 18 a model yields the measured conductance when 
the total current—Surface integral of (sigma mag(E) dot prod 
uct dS), where dS is the elemental area is divided by the 
measurement electrode Voltage, from the model or calcula 
tion results. Many books on electromagnetic field theory 
teach how to make the calculation. A specific reference is 
Chapter 6 (p. 184) in W.H. Hayt and J. A. Buck “Engineering 
Electromagnetics' 6th Edition McGraw-Hill, Boston, 2001, 
incorporated by reference herein. The specific reference 
teaches how to calculate resistance, R, but conductance, G is 
simply the reciprocal of R. G=1/R. The calculated G may be 
a complex number (for mixed materials like tissues), in which 
case the catheter 12 measures “admittance', Y, a complex 
number. 
(A) Measured Conductance and Capacitance Signals 
Two of the catheter electrodes (#1 and #4) are used to 
establish a current field in the ventricle. The current field 
results in an electric field in the tissues, the strength of which 
is determined by measuring the Voltage between electrodes 
#2 and #3. Because electrodes 2 and 3 carry negligible 
amounts of they provide a useful estimate of the electric field 
in the tissues. The current supplied to the tissue (electrodes 1 
and 4) is divided by the voltage measured between electrodes 
2 and 3 to determine the admittance of the tissue, Y (S). The 
admittance consists of two parts, the Conductance, G (S) the 
real part, and the Susceptance, B (S), the imaginary part: 
Y=G+B. In this measurement, both blood and muscle con 
tribute to the real part of the measured signal, G=G+G. 
However, after all catheter-induced effects have been 
removed, only the muscle can contribute to the imaginary 
part, B-ja) C. 
For any geometry of electric field distribution in a semi 














II reds S G = - = -
V - E. di 
(a) 
where the Surface, S. in the numerator is chosen to enclose 
all of the current from one of the electrodes used to establish 
the electric field, E, and the integration pathway in the 
denominator is from the low voltage “sink” electrode at posi 
tion “a” to the higher voltage “source' electrode at position 
“b’. Similarly, for any geometry of electric field in a dielectric 
medium, the capacitance may be calculated from: 
(b) 
V - E. di 
B) Parallel Admittance in the Cardiac Muscle 
The measured tissue signal, Y-G,Gja) C. From the 
high frequency measurement C may be determined from 
the measured phase angle by: CIY sin (0)/() after cath 
eter phase effects have been removed. By equations (a) and 
(b) above, the muscle conductance can be determined from its 
capacitance by: G =O/e C since the two equations 
differ only by their respective electrical properties i.e. the 
electric field geometry calculations are identical in a homo 
geneous medium. In this way, the muscle conductance (inde 
pendent of frequency, and thus the same in the low frequency 
and high frequency measurements) may be determined from 
the muscle capacitance (observable only in the high fre 
quency measurements). 
Beyond these very general relations, a person may make 
catheter electrode configurations of many shapes and sizes 
and use them in many sorts of conductive Solutions. All would 
have a different B(G) function. 
In an alternative embodiment, the LV Volume signal is only 
relative to LV blood conductance, but the measured admit 
tance comes from both blood and myocardium. Therefore, it 
is desired to extract the blood conductance from the measured 
admittance, which can be done by using the unique capacitive 
property of myocardium. To achieve it, the first step is to 
obtain the conductivity and permittivity of myocardium. 
Myocardial Conductivity and Permittivity 
It is believed that blood is only conductive, while myocar 
dium is both conductive and capacitive. Therefore, the mea 
sured frequency-dependent myocardial “admittivity”. Y(f), 
actually is composed of two components: 
Y, (f)=Vo, +(21 feed)? 
where O is the real myocardial conductivity, f is fre 
quency, e, is the relative myocardial permittivity, and eo is the 
permittivity of free space. Experimentally,Y(f) can be mea 
sured at two different frequencies, such as 10 and 100 kHz, 
and then the value of O, and myocardial permittivity S can be 
calculated by: 
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-continued 
1 Y (100k)? - Y, (10k)? (8) 
27t. 10 99 
Blood Conductance 
In the 10 and 100 kHz dual-frequency measurement sys 
tem, the measured magnitude of admittance, Y(f), is blood 
conductance (g) in parallel with myocardial conductance 
(g) and capacitance (C), shown as 
|Y(1Ok) -Vigg, or 10'C)? (9) 
|Y(100k)-Viggy-or-10c.) (10) 
Using equations (9) and (10), 
2it. 10 99 - 
100. |Y(10k)? - Y (100k)? (12) 
gh gn F 99 
From the well known conductance-capacitance analogy 
40, 
g = C- (13) 
0.144 
Substitute eq. (13) into eq. (12), blood conductance g, is 
obtained as 
- |-- 
A new conductance-to-volume conversion equation is 
100. |Y(10k)? - Y (100k)? (14) 
99 
Vol(t)=p, L’g, (t) expy (g, (t))f (15) 
where Vol(t) is the instantaneous volume, p, is the blood 
resistivity, L is the distance between the sensing electrodes, 
g(t) is the instantaneous blood conductance, and Y is an 
empirical calibration factor, which is determined by the fol 
lowing steps. 
1. A flow probe is used to measure the LV stroke volume 
(SV), denoted as SV. 
2.Assign an initial positive number to Y, and use equation 
(15) to convert blood conductance to volume signal. The 
resulting stroke Volume is denoted as SV. 
3. If SVY is smaller than SV, increase the value of Y. 
Otherwise, decrease it. 
4. Repeat steps 2 and 3 until it satisfies. 
SVY-SV, (16) 
Since equation (15) is a monotonic increasing function, 
there is only one possible positive solution for Y. 
This empirical factory Y is used to compensate and cali 
brate the overall uncertainty and imperfection of the measure 
ment environment, Such as inhomogeneous electrical field 














A commercial finite element software, FEMLAB, is used 
to simulate this problem. A simplified LV model is created by 
modeling both LV blood and myocardium as cylinders with a 
four-electrode catheter inserted into the center of cylinders, as 
shown in FIG. 8. 
The radius of the inner blood cylinder was changed to 
explore the relationship between Volume and conductance. 
Assuming stroke Volume is the difference between the largest 
and smallest blood volume, and this difference is used to 
determine the empirical calibration factors, C. and Y, for 
Baan’s and the new equations respectively. The calculated 
magnitude of admittance, blood conductance, true Volume, 
and estimated Volume by Baan’s and the new equations are 
listed in Table II and also plotted in FIG. 9, where the true 
Volume is the Volume between the two inner sensing elec 
trodes. The distance between two inner sensing electrodes for 
a mouse size catheter is 4.5 mm. 
TABLE II 
Comparison of true and estimated volume by two equations 
Calculated Estimated Estimated 
magnitude of Blood True volume by Baan's volume by new 
admittance conductance volume equation equation 
(LIS) (LIS) (IL) (LL) (IL) 
2491.1 2344.7 62.9 64.5 62.O 
2030.2 1853.3 43.7 51.0 43.1 
1514.O 1314.3 28.0 36.2 27.5 
1337.7 1133.5 23.5 31.2 23.0 
1162.4 956.1 19.4 26.3 19.0 
992.5 786.4 15.7 21.6 15.3 
829.3 626.2 12.4 17.2 12.0 
677.3 479.3 9.5 13.2 9.1 
S38.1 347.9 7.0 9.6 6.6 
414.4 234.2 4.9 6.4 4.4 
In Vitro Saline Experiments 
Several cylinder holes were drilled in a 1.5-inch thick block 
of Plexiglas. The conductivity of saline used to fill those holes 
was 1.03 S/m made by dissolving 0.1 M NaCl in 1 liter of 
water at 23°C. room temperature, which is about the blood 
conductivity. A conductance catheter with 9 mm distance 
between electrodes 2 and 3 is used to measure the conduc 
tance. 
Since plexiglas is an insulating material, the measured 
conductance comes from Saline only, not from the plexiglas 
wall. Therefore, the measured saline conductance corre 
sponds to the blood conductance in vivo experiments. Again, 
stroke volume is assumed to be the difference between the 
largest and Smallest blood Volume, and then used to determine 
the empirical calibration factors, C. and B, for Baans and the 
new equations, respectively. The measured data at 10kHz and 
the estimated Volume by Baans and the new equations are 
listed in Table III. The true volume listed is the volume 
between electrodes 2 and 3. The data are plotted in FIG. 10. 
TABLE III 
Comparison of true and estimated volume in the drilled holes 
Estimated Estimated 
Diameter of Measured True volume by Baan's volume by new 
Drilled holes conductance volume equation equation 
(inch) (LIS) (IL) (LL) (IL) 
3/16 1723.5 1603 S62.O 16O.S 
/4 2675.0 28S.O 872.3 310.3 
5/16 3376.O 445.3 1100.9 494.5 
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TABLE III-continued 
Comparison of true and estimated volume in the drilled holes 
Estimated Estimated 
Diameter of Measured True volume by Baan's volume by new 
Drilled holes conductance volume equation equation 
(inch) (LIS) (IL) (IL) (IL) 
3/8 3836.4 641.3 1251.0 684.8 
/16 4171.O 827.9 1360.1 866.7 
A. 4394.3 1140.1 1432.9 1031.2 
It is found that the resulting volumes obtained from the new 
equation are much closer to the MRI data, which is believed 
to he the truth. However, more noise is found in a larger 
volume by the new method, observed in FIG. 11. The reason 
is that as the Volume increases, the exponential term of the 
new equation would amplify the noise more rapidly than the 
linear Baan’s equation. 
Although the invention has been described in detail in the 
foregoing embodiments for the purpose of illustration, it is to 
be understood that such detail is solely for that purpose and 
that variations can be made therein by those skilled in the art 
without departing from the spirit and scope of the invention 
except as it may be described by the following claims. 
What is claimed is: 
1. A method for determining cardiac performance in a 
patient from a plurality of desired wave forms received from 
electrodes placed in the patient and in communication with a 
heart chamber of the patient comprising the steps of: 
receiving and separating with a data acquisition mecha 
nism the plurality of desired wave forms at desired fre 
quencies from the electrodes; and 
determining with a computer instantaneous Volume of the 
heart chamber by applying a non-linear relationship 
between measured conductance and volume of blood in 
the heart chamber to identify mechanical strength of the 
chamber from the desired wave forms at desired fre 
quencies, the processor in communication with the data 
acquisition mechanism. 
2. The method of claim 1 including the step of a signal 
synthesizer producing the plurality of desired wave forms at 
desired frequencies for the electrodes. 
3. The method of claim 2 including the steps of the signal 
synthesizer producing the plurality of desired wave forms at 
desired frequencies simultaneously, and the data acquisition 
mechanism separating the plurality of desired wave forms at 
desired frequencies the data acquisition mechanism receives 
from the electrodes. 
4. The method of claim 3 wherein the non-linear relation 
ship depends on a number of the electrodes, dimensions and 
spacing of the electrodes, and an electrical conductivity of a 
medium in which the electrodes of the catheter are disposed. 
5. The method of claim 4 wherein the non-linear relation 
ship is 
B(G)(o-0.928S/m)-1+1.774(107,481*10 G-2057) 
where: G is the measured conductance (S), the calculations 
have been corrected to the conductivity of whole blood 
at body temperature (0.928 S/m), and 2057 is the asymp 
totic conductance in LS when the cuvette is filled with a 
large volume of whole blood. 
6. The method of claim 5 wherein the nonlinear relation 















Vol(t) = (PG|Ero - Y, Oh, 
where: B(G)=the field geometry calibration function (di 
mensionless),Y(t) the measured combined admittance, 
O, is blood conductivity, L is distance between measur 
ing electrodes, and Y, the parallel leakage admittance, 
dominated by cardiac muscle. 
7. The method of claim 6 including the step of measuring 
instantaneous pressure of the heart chamber with a pressure 
sensor in communication with the computer. 
8. The method of in claim 7 wherein the pressure sensor is 
in contact with the conductance catheter to measure ventricu 
lar pressure in the chamber. 
9. The method of claim 8 including the step of the computer 
converting conductance into a Volume. 
10. The method of claim 9 including the step of the com 
puter producing a drive signal having a plurality of desired 
wave forms at desired frequencies to drive the electrodes. 
11. The method of claim 4 wherein 
where Vol(t) is the instantaneous volume, pis the blood 
resistivity, L is the distance between the sensing elec 
trodes, g(t) is the instantaneous blood conductance, and 
Yis an empirical calibration factor. 
12. A method for determining cardiac performance in a 
patient from a plurality of desired wave forms received from 
electrodes placed in the patient and in communication with a 
heart chamber of the patient comprising the steps of receiving 
and separating the plurality of desired wave forms at desired 
frequencies from the electrodes with a data acquisition 
mechanism; and determining instantaneous Volume of the 
heart chamber with a computer by removing a muscle con 
tribution from conductance that includes contributions from 
blood and muscle with respect to the heart chamber, the 
processor in communication with the data acquisition mecha 
nism. 
13. The method of claim 12 including the step of producing 
the plurality of desired wave forms at desired frequencies for 
the electrodes with a signal synthesizer. 
14. The method of claim 13 including the step of the signal 
synthesizer producing the plurality of desired wave forms at 
desired frequencies simultaneously, and the data acquisition 
mechanism separates the plurality of desired wave forms at 
desired frequencies the data acquisition mechanism receives 
from the electrodes. 
15. The method of claim 14 including the step of the 
computer measuring complex admittance with the electrodes 
to identify the muscle contribution. 
16. The method of claim 15 wherein the complex admit 
tance is defined as 
Yp=Gm+icoCm(Ysubscript p) 
where 
Cm=capacitance component of muscle (F-Farads) (C sub 
Script m) 
() angular frequency (radians/second) (greek “omega' =2 
pif) 
Gm=conductance of muscle (S=Siemens) (G subscript m). 
17. The method of claim 16 wherein the conductance is 
defined as 
Y(t)=Gb+Gm+icoCm 
where Gb-conductance of blood (S) (G subscript b). 
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